Category: Industry & Regulatory News

FDA Approvals

Latest

Trikafta Approved by FDA for Cystic Fibrosis

Trikafta is approved for patients 12 years and older with cystic fibrosis who have at least one F508del mutation in the CFTR gene, which is estimated to represent 90% of the cystic fibrosis population.